• Carbon

    801 Thousand (Tonnes)
  • Waste

    59.37 Thousand (Tonnes)
  • Water

    13.36 Million (Cubic Meters)
  • Energy

    9.62 Million (Gigajoules)
  • Revenue

    -
Rank
Rank
Rank
BAX-N
US0718131099
UNITED STATES
Health Care

About Company

Baxter International Inc. (Baxter) (NYSE: BAX) through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

Baxter manufactures products in 27 countries and sells them in more than 100 countries. The Company operates in three segments: BioScience, Medication Delivery and Renal. Baxter generates approximately 60% of its revenues outside the United States, and maintains manufacturing and distribution facilities in a number of locations in the United States, Europe, Canada, Asia-Pacific and Latin America.

In August 2009, the Company acquired certain assets of Edwards Lifesciences Corporation related to the hemofiltration business, also known as Continuous Renal Replacement Therapy (Edwards CRRT).

Company Website: www.baxter.com
Corporate Responsibility Website: Sustainability at Baxter

Top Competitors of
Baxter International Inc

  • Bayer AG

    ESG Rank 16
    Bayer AG (ETR: BAYN) is a German management holding company with core competencies in the field of health care, nutrition and high-tech materials. ..
    Read more...

Subscribe to the
Justmeans ESG Dashboard

A subscription includes full access to Environmental, Social, and Governance Data, company comparisons, ability to share data charts, custom reports, and more.

Learn more...